New · posted Nov 11
Alnylam Pharmaceuticals · Biotechnology
Vice President, Head of Pharmacovigilance Operations, Innovation & Analytics
- Cambridge, MA +1 more
- Hybrid
- Full-time
- VP & Executive
The role
The Vice President, Head of Pharmacovigilance Operations, Innovation & Analytics SRM is a critical executive-level role responsible for defining, governing, and scaling the operating model that enables Alnylam’s Safety & Risk Management (SRM), Regulatory Sciences organization to execute on pharmacovigilance with speed, quality, and predictability across a growing and increasingly complex portfolio, both in Clinical Development and on the Market. This leader owns the integrated planning architecture, governance frameworks, resource and capacity strategy, external partner performance and delivery performance insights, including managing a large budget that enable Safety & Risk Management to execute on Alnylam pharmacovigilance regulatory duties across the world. This is a high-impact, high-visibility position at a pivotal moment: Alnylam is growing and the SRM, Regulatory Sciences organization must scale rapidly. The position will report directly to the Senior Vice President of Global Patient Safety & Risk Management. The VP will serve as a key strategic advisor to Regulatory Sciences, SRM leadership while building and leading a high-performing Pharmacovigilance Operations, Innovation & Analytics team that will accelerate the organization’s ability to safely deliver medicines to patients, both in development and market.
This position is hybrid-based and candidates must be willing to travel into our US offices either in Cambridge, MA or Philadelphia, PA.
The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).
What you need
- Bachelor’s degree in a scientific, healthcare field, with a minimum of 20 years of relevant work experience in a pharmacovigilance or related operational Biotech/Pharma global role.
- MD degree or other senior degree highly preferred.
- Must have progressive experience serving in a management role with remit including pharmacovigilance, risk management, and quality-related matters.
- Experience in leading compliance or audits with working knowledge of relevant FDA, EU, ICH guidelines, Good Pharmacovigilance Practice (GVP) regulations, governing both Safety reporting and processing for clinical trial environments, and regulatory quality aspects.
- Proven ability to design and operationalize governance models, decision-making frameworks, escalation pathways, and pharmacovigilance compliance and performance management processes.
- Demonstrated success in organizational transformation and operating model design and implementation.
- Significant experience managing strategic partnerships, CROs, and external service providers, including vendor governance, performance management, and contract oversight.
- Strong financial and business acumen, including experience partnering with Finance on forecasting, budgeting, investment planning, and scenario modeling.
- Experience developing executive-level insights, dashboards, and performance metrics to support informed decision-making and organizational transparency.
- Exceptional leadership, collaboration, and influencing skills with demonstrated success working across highly matrixed organizations and senior leadership teams.
- Strong strategic thinking and problem-solving capabilities with the ability to anticipate risks, evaluate trade-offs, and drive operational excellence.
- Excellent communication and executive presence with the ability to synthesize complex information into clear, actionable recommendations.
- Demonstrated ability to lead organizational change, build scalable operating models, and drive continuous improvement initiatives.
The candidate should be able to demonstrate and lead with a clear alignment to Alnylam Core Values including, Commitment to People, Innovation and Discovery, Sense of Urgency, Open Culture and Passion for Excellence.
What you'll do
The VP Head of Pharmacovigilance Operations, Innovation & Analytics is responsible for leading all operational aspects of the Safety and Risk Management (SRM) Expertise Area.
Key accountability includes Alnylam Pharmaceuticals Pharmacovigilance Reporting Compliance, safety information case management, a foundational role to scientific knowledge building for all Alnylam development and commercial products, Pharmacovigilance processes innovation and implementation, including business partners vendor management.
- Build and lead high-performing Pharmacovigilance Operations, Innovation & Analytics teams, providing strategic oversight and financial soundness.
- Provide strategic leadership and oversight of process design, evaluation and review of all SRM procedures, PV operational innovation and excellence;
- Foster strong partnerships with Commercial and Medical Affairs, Clinical Operations, Quality Assurance, Data Management, IT, Finance, and external partners.
- Collaborates and partners with Alnylam Quality Assurance department to ensure the effective management and conduct of audits and inspections and to promote a successful PV Quality Management System
- Ensures all relevant SOPs and systems/ processes are in place making for an efficient and compliant Safety & Risk management organization
- Provides strategic consultation and guidance to all EAs in development and commercial/Medical Affairs on all decisions that have significant pharmacovigilance operative implications, including safety reporting operational aspects of postmarketing studies, market research activities, Patient Access programs (ie Alnylam Assist);
- Oversees tracking of KPIs for reporting of compliance metrics related to SRM and Regulatory Quality activities;
- Provides strategic leadership and input into the system requirements and process design for pharmacovigilance operations and analytics, collaborating with IT in ensuring efficient and high quality PV systems are in effect, including Argus, PVReports, & Empirica and any other IT systems;
- In partnership with the QPPV, provides strategic direction and quality and compliance leadership to SRM;
- Define and execute PV vendor strategy, ensuring strong governance, clear accountability, and high-performing partnerships that enable speed, quality, and cost efficiency while keeping an enterprise lens.
- Provide strategic leadership and performance management of external partners — including Case Management / Medical Review vendors, clinical trial safety reporting vendors across all trials;
- Drive vendor strategy, governance frameworks, and accountability mechanisms to ensure high-quality, cost-effective delivery. Ensure partner performance is aligned to safety reporting regulations and obligation timelines and organizational priorities.
- Lead governance of Case Management / Medical Review and other partner relationships with a focus on value realization and risk mitigation.
- Serve as a key strategic advisor to senior leaders on operating model design, systems strategy, and execution effectiveness.
- Champion a culture of collaboration, transparency, accountability, and innovation.
- Develop organizational capabilities that enable the company to scale and deliver across development and commercial pharmacovigilance activities.
Pay and benefits
$289,000 – $391,000 a year
Employer providedMedical, dental, and vision coverage
Life and disability insurance
401(k) with company match
Paid time off, wellness days and holidays
Annual bonus and equity eligibility
Family resources and leave
Where you'll work
Cambridge, MA +1 moreHybridOpen in Maps (opens in a new tab)
Also posted for: Philadelphia, PA
More jobs in Cambridge, MA +1 more
From the posting
About Alnylam
We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.
Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.
Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers
U.S. Pay Range
$289,000—$391,000 USD
Equal opportunity, accessibility and legal noticesAlnylam Pharmaceuticals's statements, word for word
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.
Before applying, please review Alnylam's Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.
Job intelligence
The context around this role
Live data · November 11, 2026
Salary intelligence
How the pay compares
This role's midpoint is 2% below the US median for Clinical Safety & Pharmacovigilance roles at this level.
This roleEmployer provided
VP & Executive roles in the US13 roles publishing pay
| Annual base pay | Low | Median | High |
|---|---|---|---|
| This role | $289,000 | — | $391,000 |
| All US (middle half) | $346,500 | $346,500 | $378,000 |
This role: Alnylam Pharmaceuticals's own published range. Comparisons: the base pay employers published on open Clinical Safety & Pharmacovigilance roles at the same level on Regulatory Jobs, November 11, 2026. Nothing is estimated.
Career trajectory
Where this role sits in Clinical Safety & Pharmacovigilance
The general path across 160 open Clinical Safety & Pharmacovigilance roles on Regulatory Jobs, with the titles they carry most. Not Alnylam's own promotion track.
Skills DNA
What this role leans on
How many of the posting's 35 duty, requirement and summary lines touch each area. The posting's emphasis, not a proficiency score.
- Collaboration and leadership13
- GMP and compliance7
- Quality systems and risk6
- Documentation and SOPs4
- Clinical trial conduct4
- Data and digital systems1
Regulatory intelligence
The rules, regulations and standards behind this role
The regulations, guidance and standards that govern Clinical Safety & Pharmacovigilance work in biotechnology, led by the one this posting names, each linked to the agency or standards body that publishes it.
- EMAEU Good Pharmacovigilance Practices (GVP)(official source, opens in a new tab)EMA's modules for pharmacovigilance systems, signals and periodic reportsNamed in the posting
- FDA21 CFR 314.80 and 600.80(official source, opens in a new tab)Postmarketing reporting of adverse drug and biologic experiences
- ICHICH E2A to E2F(official source, opens in a new tab)Clinical safety data management, expedited reporting and periodic safety reports
- FDAFDA good pharmacovigilance practices(official source, opens in a new tab)Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment
- FDAFDA FAERS(official source, opens in a new tab)The FDA Adverse Event Reporting System for drugs and biologics
- EUDirective 2001/83/EC(official source, opens in a new tab)The EU code for medicinal products for human use: authorization, labeling, pharmacovigilance
- ISOISO 19011(official source, opens in a new tab)Guidelines for auditing management systems
- ICHMedDRA(official source, opens in a new tab)The ICH medical terminology for coding adverse events and medical history
- FDAFDA REMS(official source, opens in a new tab)Risk Evaluation and Mitigation Strategies for drugs with serious safety concerns
- FDA21 CFR Part 312(official source, opens in a new tab)Investigational New Drug applications and sponsor duties in drug trials
- ICHICH E6(R3) good clinical practice(official source, opens in a new tab)The international standard for the design, conduct and reporting of clinical trials
- FDA21 CFR Parts 600 to 680(official source, opens in a new tab)FDA standards for biological products, from licensing to lot release
- FDA21 CFR Part 201(official source, opens in a new tab)FDA labeling requirements for drugs, including prescribing information
- FDA21 CFR Part 11(official source, opens in a new tab)FDA rules for electronic records and electronic signatures
- Health CanadaCanada Food and Drug Regulations(official source, opens in a new tab)Health Canada's regulations for drugs, including GMP (Part C, Division 2)
- MHRAUK MHRA(official source, opens in a new tab)The UK regulator of medicines and medical devices, including UKCA marking
From Regulatory News
Manufacturing and quality coverage for this professionCompany hiring pulse
Alnylam on Regulatory Jobs
- 15
- Open roles
- 15
- Distinct roles
- 4
- Locations
By discipline
- Clinical9 60%
- Regulatory3 20%
- Quality3 20%
By level
- Director9 60%
- Manager2 13%
- Associate & Specialist2 13%
More roles at Alnylam
- View role
Director, Pharmacovigilance & Safety Technology
Cambridge, MA · HybridDirectorBiotechnologySalary not listed
- View role
Senior Director, Global Pharmacovigilance Quality Assurance Lead
Cambridge, MA +2 more · HybridDirectorBiotechnology$228K
- View role
Director, Clinical Research- Benign Hematology
Cambridge, MA · HybridDirectorBiotechnologySalary not listed
- View role
Director, Clinical Science
Cambridge, MA · HybridDirectorBiotechnology$206K
Similar Clinical Safety & Pharmacovigilance roles elsewhere
- View role
Vice President, Pharmacovigilance
Crescent BiopharmaWaltham, MA · HybridVP & ExecutiveBiotechnology$323K–$357K
- View role
Head, US Patient Safety
GenentechSouth San Francisco, CAVP & ExecutiveBiotechnology$282K–$524K
- View role
Head of Pharmacovigilance
Praxis Precision MedicinesRemote, USVP & ExecutiveBiotechnology$378K
- View role
Vice President, Pharmacovigilance and Drug Safety (Head of Pharmacovigilance and Drug Safety)
ORIC PharmaceuticalsSan Diego, CAVP & ExecutiveBiotechnology$310K–$385K
Vice President, Head of Pharmacovigilance Operations, Innovation & Analytics at Alnylam
Open until filled. $289K–$391K a year, employer provided.